Real-time enrollment status for this chronic inflammatory demyelinating polyneuropathy clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:50 AM UTC
| NCT Number | NCT07032662 |
| Recruiting Status | Recruiting |
| Condition | Chronic Inflammatory Demyelinating Polyneuropathy |
| Phase | PHASE2 |
| Target Enrollment | 162 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Immunovant Sciences GmbH |
| Last Updated on CT.gov | September 30, 2026 (2 weeks ago) |
As of October 16, 2026: Clinical trial NCT07032662 is currently recruiting participants. This phase2 study for chronic inflammatory demyelinating polyneuropathy is actively seeking new participants at 33 locations across the United States. The study is sponsored by Immunovant Sciences GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07032662 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07032662 was last updated 2 weeks ago (September 30, 2026). HelloStudys verifies this status automatically.